Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Pui

Showing results (131-140 of 414) with videos related to

Pageof 42
Sort By:
AJNR. American Journal of Neuroradiology|August 1, 2009
Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemiaW E Reddick, J O Glass, D P Johnson, et al.
Cancer|June 15, 1983
Hydrocele formation in patients with Hodgkin's diseaseC H Pui, J Wilimas, E Thompson, et al.
Medical and Pediatric Oncology|September 1, 1997
Systemic hemophagocytosis masking the diagnosis of large cell non-Hodgkin lymphomaJ T Sandlund, W M Roberts, C H Pui, et al.
Blood|June 15, 1992
Hyperdiploid (47-50) acute lymphoblastic leukemia in childrenS C Raimondi, P K Roberson, C H Pui, et al.
Blood|February 1, 1996
Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangementsF G Behm, F O Smith, S C Raimondi, et al.
Medical and Pediatric Oncology|January 1, 1993
Adverse prognostic features in 251 children treated for acute myeloid leukemiaC A Hurwitz, M J Schell, C H Pui, et al.
Cancer|November 15, 1990
Testicular relapse in children with acute nonlymphoblastic leukemiaW L Furman, J Fontanesi, O Hustu, et al.
Lancet (London, England)|December 22, 1984
Seizures in childhood lymphoblastic leukaemia patientsJ J Ochs, W P Bowman, C H Pui, et al.
Journal of the National Cancer Institute|August 29, 2012
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemiaH M Conklin, K R Krull, W E Reddick, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Use of the automatic interaction detector method to identify patient characteristics related to methotrexate clearanceW R Crom, A M Glynn, M Abromowitch, et al.
Pageof 42

Showing results (131-140 of 414) with videos related to

Sort By:
Pageof 42
AJNR. American Journal of Neuroradiology|August 1, 2009
Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemiaW E Reddick, J O Glass, D P Johnson, et al.
Cancer|June 15, 1983
Hydrocele formation in patients with Hodgkin's diseaseC H Pui, J Wilimas, E Thompson, et al.
Medical and Pediatric Oncology|September 1, 1997
Systemic hemophagocytosis masking the diagnosis of large cell non-Hodgkin lymphomaJ T Sandlund, W M Roberts, C H Pui, et al.
Blood|June 15, 1992
Hyperdiploid (47-50) acute lymphoblastic leukemia in childrenS C Raimondi, P K Roberson, C H Pui, et al.
Blood|February 1, 1996
Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangementsF G Behm, F O Smith, S C Raimondi, et al.
Medical and Pediatric Oncology|January 1, 1993
Adverse prognostic features in 251 children treated for acute myeloid leukemiaC A Hurwitz, M J Schell, C H Pui, et al.
Cancer|November 15, 1990
Testicular relapse in children with acute nonlymphoblastic leukemiaW L Furman, J Fontanesi, O Hustu, et al.
Lancet (London, England)|December 22, 1984
Seizures in childhood lymphoblastic leukaemia patientsJ J Ochs, W P Bowman, C H Pui, et al.
Journal of the National Cancer Institute|August 29, 2012
Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemiaH M Conklin, K R Krull, W E Reddick, et al.
Clinical Pharmacology and Therapeutics|May 1, 1986
Use of the automatic interaction detector method to identify patient characteristics related to methotrexate clearanceW R Crom, A M Glynn, M Abromowitch, et al.
Pageof 42